JW Therapeutics CEO China Pharma Sector Unaffected by Beijings Tech Deal Scrutiny
Indian Indices Remain RangeBound as Market Awaits Direction
HELOC and Home Equity Loan Rates May 24 2026 Truist Named Best Lender Amidst Competitive Rates
Paul Tudor Jones Sees No Chance of Rate Cuts Under Potential Fed Chair Kevin Warsh
Citi Research Warns El Nino and Strait of Hormuz Risks Could Drive Global Food Inflation Higher
Why the US 10Year Bond Yield Matters More Than Most Investors Realise
GOOGL Q1 2026 Earnings EPS Miss Amidst AI Investment Pressures
CVU Q1 2021 Earnings Strong EPS Beat Drives Positive Stock Reaction
LyondellBasell LYB Q1 2026 Earnings Surprise EPS Beat Fails to Lift Shares as Market Focuses on Demand Concerns
Central Garden Pet Company CENTA Q1 2026 Earnings Earnings Beat Driven by Operational Discipline Amid Mixed TopLine Signals
Nexstar Media Group NXST Q1 2026 Earnings EPS Beats Estimates by Over 13 Despite Flat Revenue Outlook
Telus Q1 2026 Earnings EPS Beats Expectations Amid Cautious Growth Outlook
Preformed Line Products PLPC Surges 39 as Momentum Builds Toward Key Resistance
PetMed Express PETS Faces Continued Pressure Amid 36 Decline Testing Key Support Levels
Vine Hill Capital Investment Corp II Units VHCPU Holds Steady at 1002 Amid SPAC Trading Patterns
Johnson Controls International JCI Slightly Lower Amid Broad Market Uncertainty Support Levels in Focus
GIBO Holdings GIBO Edges Higher Key Support and Resistance Levels in Focus
Prediction Markets Surge Among Young Male Demographics Industry Reaches MultiBillion Dollar Scale
SSB Q1 2026 Earnings Slight EPS Beat Drives Modest Stock Uptick
Nucor Corporation NUE Edges Higher Amid Steel Sector Resilience
LMAT Q1 2026 Earnings Modest EPS Beat Amid Revenue Data Gap
TransCode Therapeutics Q4 2024 Earnings Deep Losses Reflect PreRevenue Stage
Ares Management ARES Q1 2026 Earnings EPS Misses Street View but Stock Gains on Resilient Business Trends
RCON Q4 2025 Earnings EPS Surprise Beats Estimates Amid Revenue Uncertainty
BioRad Q1 2026 Earnings Earnings Miss Estimates Despite Stock Rally
Iveda Solutions Q2 2024 Earnings EPS Surpasses Estimates Despite Minimal Revenue Data
Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path